Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  methylprednisolone
Find trials that include:  Any drugs shown
Results 1-11 of 11 for your search:
Start Over
Combination Chemotherapy with or without Rituximab in Treating Younger Patients with Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and under
Trial IDs: ANHL1131, NCI-2012-01963, 2010-019224-31, CDR0000732604, IGR2009/1593, COG-ANHL1131, NCT01595048
AP1903 and Genetically Modified Donor T Cells after Donor Stem Cell Transplant in Treating Patients with Hematologic Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 65
Trial IDs: 2012-0501, NCI-2013-01666, RM00000684-RN00, NCT01875237
Obinutuzumab and High-Dose Methylprednisolone in Treating Patients with Chronic Lymphocytic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UCSD GA101+HDMP, NCI-2014-01950, 140396, GA101-HDMP, NCT02229422
Tretinoin and Arsenic Trioxide with or without Gemtuzumab Ozogamicin in Treating Patients with Previously Untreated Acute Myeloid Leukemia
Phase: Phase II
Type: Treatment
Age: 10 and over
Trial IDs: 2010-0981, NCI-2011-02767, NCT01409161
Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients with Acute Lymphoblastic Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2011-0030, NCI-2011-02941, NCT01424982
Phase II Ofatumumab/Methylprednisolone Followed by Ofatumumab/Lenalidomide for Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MCC-16622, NCI-2012-00066, GSK OFT114879, RV-CLL-PI-0560, NCT01496976
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low or Intermediate-Risk Hodgkin Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: H-30993, NCI-2013-01346, TXCH-HD-12A, NCT01858922
Methylprednisolone Sodium Succinate in Treating Patients with Acute Graft-versus-Host Disease of the Gastrointestinal Tract
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CCCWFU 98115, NCI-2015-00548, NCT02425813
Donor Stem Cell Transplant after Busulfan and Fludarabine Phosphate with or without Anti-thymocyte Globulin in Treating Patients with Inherited Metabolic Disorders, Severe Osteopetrosis, or Rett Syndrome
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 55 and under
Trial IDs: 2013LS104, NCI-2014-02309, 1406M51542, MT2013-31, NCT02171104
Start Over